Extension of nonoperative management of blunt pancreatic trauma to include grade III injuries: a safety analysis.

Giacomo Pata, Claudio Casella, Ernesto Di Betta, Luigi Grazioli, Bruno Salerni
Author Information
  1. Giacomo Pata: Department of Medical and Surgical Sciences, 1st Division of General Surgery, University of Brescia, Viale Europa, 11, 25123, Brescia, Italy. giacomopata@alice.it

Abstract

BACKGROUND: In hemodynamically stable PATIENTS after blunt pancreatic Trauma, the main pancreatic duct (MPD) disruption (American Association for the Surgery of Trauma [AAST] grade III-IV-V lesions) is usually treated surgically or by endoscopic stent placement, whereas injuries without duct involvement (grade I-II) are liable to medical treatment. To date, no evidence has been reported regarding nonoperative management (NoM) of grade III injuries. We aimed to evaluate the safety of extending medical management to include cases of distal MPD involvement (grade III).
PATIENTS AND METHODS: Data were collected on PATIENTS admitted after blunt pancreatic Trauma between January 1999 and December 2007. PATIENTS exhibiting hemodynamic instability or hollow organ perforations were excluded from this study, as they were surgically managed. In all remaining cases NoM was attempted. Antibiotic prophylaxis and early total enteral nutrition were routinely adopted. Grade III PATIENTS received octreotide during hospitalization and for 6 months after discharge.
RESULTS: Eleven PATIENTS (2 with grade I injury, 3 with grade II injury, and 6 with grade III injury, all diagnosed by contrast-enhanced helical CT) were included. Nonsurgical management was carried out in all of these PATIENTS. Among grade III PATIENTS, one developed a peripancreatic abscess; another, a pancreatic fistula. Both were successfully treated nonoperatively. The average length of hospital stay was similar in grade I-II and grade III PATIENTS. After a median follow-up of 57 months no mortality or pancreatic sequelae had occurred.
CONCLUSIONS: Under the aforementioned conditions, an attempt to extend NoM to include PATIENTS with AAST-grade III lesions can be justified. However, such a strategy demands continuous patient monitoring, because should the case worsen, surgery might become necessary.

References

  1. Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 1):686-93 [PMID: 17925768]
  2. J Pediatr Surg. 1998 Feb;33(2):343-9 [PMID: 9498414]
  3. Aliment Pharmacol Ther. 1998 Mar;12(3):237-45 [PMID: 9570258]
  4. World J Surg. 2005 Oct;29(10):1325-8 [PMID: 16132406]
  5. Br J Surg. 1995 Sep;82(9):1236-9 [PMID: 7552005]
  6. JOP. 2003 Jan;4(1):33-40 [PMID: 12555014]
  7. JOP. 2005 Mar 10;6(2):152-61 [PMID: 15767731]
  8. J Trauma. 2008 Mar;64(3):666-72 [PMID: 18332806]
  9. Ann Surg. 1998 Jun;227(6):861-9 [PMID: 9637549]
  10. Nutrition. 2002 Mar;18(3):259-62 [PMID: 11882400]
  11. Surg Clin North Am. 2007 Dec;87(6):1503-13, x [PMID: 18053844]
  12. Semin Ultrasound CT MR. 1996 Apr;17(2):177-82 [PMID: 8845200]
  13. Endoscopy. 1992 Jan-Feb;24(1-2):176-84 [PMID: 1559490]
  14. Am Surg. 1997 Jul;63(7):598-604 [PMID: 9202533]
  15. Gastrointest Endosc. 2000 Jan;51(1):1-7 [PMID: 10625786]
  16. J Trauma. 2000 Jun;48(6):1001-7 [PMID: 10866243]
  17. Surg Endosc. 2006 Oct;20(10):1551-5 [PMID: 16897285]
  18. J Trauma. 1986 Oct;26(10):874-81 [PMID: 3095557]
  19. Am J Surg. 2007 May;193(5):641-3; discussion 643 [PMID: 17434373]
  20. Gastrointest Endosc. 2006 Nov;64(5):726-31 [PMID: 17055865]
  21. Br J Surg. 1997 Dec;84(12):1665-9 [PMID: 9448611]
  22. Ann Surg. 1992 May;215(5):503-11; discussion 511-3 [PMID: 1616387]
  23. Surg Endosc. 2005 May;19(5):665-9 [PMID: 15759197]
  24. Am J Gastroenterol. 2002 Sep;97(9):2255-62 [PMID: 12358242]
  25. Int J Pancreatol. 1995 Apr;17(2):203-6 [PMID: 7622943]
  26. Eur J Med Res. 2000 Apr 19;5(4):165-70 [PMID: 10799351]
  27. J Comput Assist Tomogr. 1997 Mar-Apr;21(2):246-50 [PMID: 9071293]
  28. Surgery. 1994 Oct;116(4):622-7 [PMID: 7524175]
  29. Am J Gastroenterol. 1991 Apr;86(4):519-21 [PMID: 1672789]
  30. J Trauma. 2004 Apr;56(4):774-8 [PMID: 15187740]
  31. Am J Gastroenterol. 1980 Dec;74(6):493-6 [PMID: 7211811]
  32. Gut. 2001 Dec;49 Suppl 4:iv32-9 [PMID: 11878792]
  33. JPEN J Parenter Enteral Nutr. 1997 Jan-Feb;21(1):14-20 [PMID: 9002079]
  34. Gut. 1999 Jul;45(1):97-104 [PMID: 10369711]
  35. Injury. 2001 Dec;32(10):753-9 [PMID: 11754881]
  36. Dig Liver Dis. 2001 Mar;33(2):192-201 [PMID: 11346150]
  37. Am J Gastroenterol. 1992 Mar;87(3):387-91 [PMID: 1539580]
  38. J Pediatr Surg. 2001 May;36(5):823-7 [PMID: 11329598]
  39. J Pediatr Surg. 1999 Nov;34(11):1736-9 [PMID: 10591583]
  40. Gut. 1998 Mar;42(3):431-5 [PMID: 9577354]
  41. Am J Surg. 1994 Oct;168(4):345-7 [PMID: 7943592]
  42. Pancreatology. 2003;3(5):406-13 [PMID: 14526151]
  43. Eur J Surg. 2000 Jan;166(1):4-12 [PMID: 10688209]
  44. Surg Today. 1999;29(5):458-61 [PMID: 10333420]
  45. Pancreas. 2008 Jan;36(1):18-25 [PMID: 18192875]
  46. Am J Gastroenterol. 2007 Jan;102(1):52-5 [PMID: 17266688]
  47. Am Surg. 2002 Aug;68(8):704-7; discussion 707-8 [PMID: 12206605]
  48. Am Surg. 2001 Mar;67(3):227-30; discussion 230-1 [PMID: 11270879]

MeSH Term

Adult
Antibiotic Prophylaxis
Contrast Media
Enteral Nutrition
Female
Follow-Up Studies
Gastrointestinal Agents
Humans
Length of Stay
Male
Middle Aged
Octreotide
Pancreas
Severity of Illness Index
Tomography, X-Ray Computed
Wounds, Nonpenetrating

Chemicals

Contrast Media
Gastrointestinal Agents
Octreotide

Word Cloud

Created with Highcharts 10.0.0gradepatientsIIIpancreaticmanagementblunttraumaNoMincludeinjuryductMPDlesionstreatedsurgicallyinjuriesinvolvementI-IImedicalnonoperativesafetycases6monthsBACKGROUND:hemodynamicallystablemaindisruptionAmericanAssociationSurgeryTrauma[AAST]III-IV-VusuallyendoscopicstentplacementwhereaswithoutliabletreatmentdateevidencereportedregardingaimedevaluateextendingdistalPATIENTSANDMETHODS:DatacollectedadmittedJanuary1999December2007PatientsexhibitinghemodynamicinstabilityholloworganperforationsexcludedstudymanagedremainingattemptedAntibioticprophylaxisearlytotalenteralnutritionroutinelyadoptedGradereceivedoctreotidehospitalizationdischargeRESULTS:Eleven23IIdiagnosedcontrast-enhancedhelicalCTincludedNonsurgicalcarriedAmongonedevelopedperipancreaticabscessanotherfistulasuccessfullynonoperativelyaveragelengthhospitalstaysimilarmedianfollow-up57mortalitysequelaeoccurredCONCLUSIONS:aforementionedconditionsattemptextendAAST-gradecanjustifiedHoweverstrategydemandscontinuouspatientmonitoringcaseworsensurgerymightbecomenecessaryExtensioninjuries:analysis

Similar Articles

Cited By